UBS Group’s Celanese CE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-18,600
Closed -$783K 10561
2025
Q3
$783K Buy
+18,600
New +$926K ﹤0.01% 5755
2025
Q1
Sell
-3,000
Closed -$208K 10265
2024
Q4
$208K Buy
+3,000
New +$288K ﹤0.01% 6432
2018
Q4
Sell
-18,500
Closed -$2.11M 8039
2018
Q3
$2.11M Hold
18,500
﹤0.01% 3182
2018
Q2
$2.06M Buy
+18,500
New +$2.04M ﹤0.01% 3139
2017
Q2
Sell
-89,352
Closed -$8.03M 7693
2017
Q1
$8.03M Buy
+89,352
New +$7.8M ﹤0.01% 1678
2016
Q2
Sell
-89,352
Closed -$5.85M 7739
2016
Q1
$5.85M Buy
+89,352
New +$5.54M ﹤0.01% 1733
2015
Q3
Sell
-200
Closed -$14K 8419
2015
Q2
$14K Sell
200
-2,300
-92% -$153K ﹤0.01% 7181
2015
Q1
$140K Sell
2,500
-300
-11% -$17K ﹤0.01% 5160
2014
Q4
$168K Buy
+2,800
New +$164K ﹤0.01% 5205

Other funds holding CE

UBS Group's CE Position: Q2 2026 in Review

UBS Group increased its Celanese (CE) stake by 41% in Q2 2026, buying an estimated $28.7M and bringing the position to 1,694,396 shares worth $77.9M. The position accounts for 0.01% of the portfolio, ranked #1316.

UBS Group first reported a position in CE in Q4 2014 and has held it in 47 quarters since. The position peaked at $102M in Q4 2024. 461 funds tracked by Wall St. Rank hold CE as of Q2 2026.

  • UBS Group held 1,694,396 shares of Celanese worth $77.9M as of Q2 2026.
  • UBS Group bought 496,242 Celanese shares in Q2 2026, an estimated $28.7M.
  • Celanese made up 0.01% of UBS Group's portfolio in Q2 2026, its #1316 holding.
  • UBS Group first reported a position in Celanese in Q4 2014 and has held it in 47 quarters since.
  • UBS Group's Celanese position peaked at $102M in Q4 2024.
  • 461 funds tracked by Wall St. Rank held Celanese as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.